Therapeutic Plasma Exchange After Spontaneous Intracranial Hemorrhage for a Patient With Antiphospholipid Syndrome and Lupus Anticoagulant Hypoprothrombinemia
Journal of Clinical Apheresis · 2025
DOI: 10.1002/jca.70064 ↗At a glance
Fallbericht in Journal of Clinical Apheresis, 2025. Written by Joshua Nicholas and 4 co-authors. Institution: Department of Anesthesiology, Perioperative and Pain Medicine, University of Calgary Cumming School of Medicine, Calgary, Alberta, Canada. Major MEDLINE topics: Antiphospholipid Syndrome, Plasma Exchange, Lupus Coagulation Inhibitor, Hypoprothrombinemias. 10 references. The full text is freely available (open access, CC BY-NC-ND 4.0).
Abstract (original language)
Antiphospholipid syndrome (APS) is characterized by the presence of antiphospholipid antibodies (aPL), macro‐ and micro‐vascular thromboembolic complications. Lupus anticoagulant‐hypoprothrombinemia (LAHPS) may confound the diagnosis and management of bleeding. Catastrophic APS has a category 1 indication for therapeutic plasma exchange (TPE). However, in patients with APS, LAHPS, and intracranial hemorrhage (ICH), TPE is not well described. A 47‐year‐old man with known APS anticoagulated on warfarin was transferred for diffuse spontaneous subdural hemorrhages (SDH) with somnolence. aPL levels were elevated on presentation; anti‐β2‐glycoprotein‐I antibody (aβ2GPI) IgG was higher than the reportable range. Factor II activity level was 20% despite holding warfarin: concerning for LAHPS. TPE was initiated to minimize risk of thromboembolism while holding anticoagulation. Level of consciousness improved by the second TPE. An acute lacunar infarct was detected on MRI, but this may have occurred before initiating TPE. Measures of lupus anticoagulant and anticardiolipin (aCL) IgG decreased initially, but aβ2GPI IgG remained above the reportable range. Both aCL and aβ2GPI IgM titers increased initially but decreased by day 31. Factor II activity level improved but remained below normal. Serial imaging showed resolution of SDH without new infarction. In patients with APS and recurrent thromboembolic disease, assessment and treatment of ICH may be confounded by LAHPS. Reversal of anticoagulation is reserved for patients in extremis, and treatment of LAHPS has previously been associated with thrombosis. In this context, TPE may be considered in combination with steroids and rituximab to bridge overlapping thromboembolic and hemorrhagic risk.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Department of Anesthesiology, Perioperative and Pain Medicine, University of Calgary Cumming School of Medicine, Calgary, Alberta, Canada.
- Department of Medicine, Division of Hematology and Oncology, University of Pittsburgh School of Medicine, Pennsylvania, USA.
- Department of Medicine, Division of Hematology, Stanford University School of Medicine, Stanford, USA.
- Department of Pathology, Division of Transfusion Medicine, Stanford University School of Medicine, California, USA.
ORCID profiles: Joshua Nicholas
Cite
APA
Nicholas, J., Wali, J., Ellis-Caleo, T., Virk, M. S., & Yunce, M. (2025). Therapeutic Plasma Exchange After Spontaneous Intracranial Hemorrhage for a Patient With Antiphospholipid Syndrome and Lupus Anticoagulant Hypoprothrombinemia. Journal of Clinical Apheresis. https://doi.org/10.1002/jca.70064
Vancouver
Nicholas J, Wali J, Ellis-Caleo T, Virk MS, Yunce M. Therapeutic Plasma Exchange After Spontaneous Intracranial Hemorrhage for a Patient With Antiphospholipid Syndrome and Lupus Anticoagulant Hypoprothrombinemia. Journal of Clinical Apheresis. 2025. doi:10.1002/jca.70064
BibTeX
@article{Nicholas2025,
author = {Nicholas, Joshua and Wali, Junaid and Ellis-Caleo, Timothy and Virk, Mrigender Singh and Yunce, Muharrem},
title = {Therapeutic Plasma Exchange After Spontaneous Intracranial Hemorrhage for a Patient With Antiphospholipid Syndrome and Lupus Anticoagulant Hypoprothrombinemia},
journal = {Journal of Clinical Apheresis},
year = {2025},
doi = {10.1002/jca.70064}
}
EUVIMED